Reuters logo
BRIEF-Glenmark Pharma expects to launch 20 generic products annually in U.S.
December 19, 2016 / 9:10 AM / a year ago

BRIEF-Glenmark Pharma expects to launch 20 generic products annually in U.S.

Dec 19 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says Glenmark expects to file 2025 ANDAs and launch 20 generic products annually in the U.S. Source text: bit.ly/2hLg0qA Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below